Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Ventura2020on Oct 22, 2020 10:19am
132 Views
Post# 31761536

Aphria Leads Market Share

Aphria Leads Market Share

Canadian sales of legal adult-use cannabis grew by 5.2% from July to August, reaching a monthly total of 244.9 million Canadian dollars ($186.9 million).

The monthly record for Canadian marijuana sales implies an annualized market worth more than CA$2.9 billion.

Statistics Canada’s retail trade data for August tracked sales in all 10 provinces, plus the Northwest Territories and Yukon.

In Ontario, recreational cannabis sales grew by 10.9% on a monthly basis to CA$66.9 million.

Quebec experienced more modest monthly growth, with sales increasing by 1.7% to CA$44.6 million.

British Columbia’s licensed cannabis retailers sold 5.3% more marijuana products in August than in July, with sales reaching CA$36.5 million.

Alberta, the fourth-largest province by population and home to the most cannabis stores of any Canadian jurisdiction, saw monthly sales growth slow to 1.5%, with CA$52.6 million of cannabis sold in August.

In Manitoba, where a new wave of licensed cannabis stores began opening in late summer, monthly sales grew by 5.5% in August to CA$9.6 million.

Saskatchewan posted monthly sales of CA$12.9 million, a 1.6% increase over July.

Monthly sales and growth in Canada’s smaller Atlantic provinces were:

  • Nova Scotia: CA$7.6 million (+8.7%).
  • New Brunswick: CA$6.7 million (+3.8%).
  • Newfoundland: CA$4.7 million (+13.5%).
  • Prince Edward Island: CA$1.7 million (+8.1%).

August sales in the Northwest Territories and Yukon were CA$412,000 and CA$723,000, respectively.

Statistics Canada is scheduled to release retail trade figures for September on Nov. 20.

 
<< Previous
Bullboard Posts
Next >>